These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30500522)

  • 1. The first target specific, highly diastereoselective synthesis, design and characterization of pyranoquinolinyl acrylic acid diastereomers as potential α-glucosidase inhibitors.
    Lavanya G; Venkatapathy K; Magesh CJ; Ramanathan M; Jayasudha R
    Bioorg Chem; 2019 Mar; 84():125-136. PubMed ID: 30500522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.
    Nikookar H; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Ranjbar PR; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Apr; 77():280-286. PubMed ID: 29421703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.
    Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA
    Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors.
    Wang G; Peng Z; Gong Z; Li Y
    Bioorg Chem; 2018 Aug; 78():195-200. PubMed ID: 29587132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinazolinone-dihydropyrano[3,2-b]pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokinetic.
    Sherafati M; Mirzazadeh R; Barzegari E; Mohammadi-Khanaposhtani M; Azizian H; Sadegh Asgari M; Hosseini S; Zabihi E; Mojtabavi S; Ali Faramarzi M; Mahdavi M; Larijani B; Rastegar H; Hamedifar H; Hamed Hajimiri M
    Bioorg Chem; 2021 Apr; 109():104703. PubMed ID: 33609917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.
    Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA
    Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
    Wang G; He D; Li X; Li J; Peng Z
    Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase.
    Özil M; Emirik M; Beldüz A; Ülker S
    Bioorg Med Chem; 2016 Nov; 24(21):5103-5114. PubMed ID: 27576293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors.
    Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li X; Li J
    Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
    Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro α-glucosidase inhibitory activity and molecular docking studies of new thiazole derivatives.
    Khan KM; Qurban S; Salar U; Taha M; Hussain S; Perveen S; Hameed A; Ismail NH; Riaz M; Wadood A
    Bioorg Chem; 2016 Oct; 68():245-58. PubMed ID: 27592296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.
    Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU
    Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
    Wang G; Chen M; Qiu J; Xie Z; Cao A
    Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs.
    Javid MT; Rahim F; Taha M; Rehman HU; Nawaz M; Wadood A; Imran S; Uddin I; Mosaddik A; Khan KM
    Bioorg Chem; 2018 Aug; 78():201-209. PubMed ID: 29597114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.
    Heydari Z; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Mahdavi M; Ranjbar PR; Larijani B
    Med Chem; 2019; 15(1):8-16. PubMed ID: 29807519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyrano [2,3-c] pyrazole: Novel in vitro inhibitors of yeast α-glucosidase.
    Kashtoh H; Muhammad MT; Khan JJ; Rasheed S; Khan A; Perveen S; Javaid K; Atia-Tul-Wahab ; Khan KM; Choudhary MI
    Bioorg Chem; 2016 Apr; 65():61-72. PubMed ID: 26874344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
    Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
    Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li J; Li X
    Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
    Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.